| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -13,382 | -2,615 | -11,146 | -37,303 |
| Depreciation and amortization | 2,478 | 2,485 | 2,388 | 4,690 |
| Provision for credit losses | 217 | 578 | 810 | 1,964 |
| Provision for inventory obsolescence | 1,300 | 428 | 764 | 1,454 |
| Change in reserve for pp&e impairment | NaN | 0 | NaN | NaN |
| Provision for deferred income taxes | NaN | -9,130 | NaN | NaN |
| Share-based compensation | 3,003 | 2,902 | 2,894 | 5,619 |
| Loss from disposal of property and equipment | -47 | -97 | -64 | 8 |
| Non-cash loss on contract termination | NaN | 0 | 0 | -543 |
| Unrealized foreign currency gain, net | 428 | -56 | 531 | 9,481 |
| Amortization of right-to-use asset | 214 | 285 | 154 | 472 |
| Stock compensation in lieu of cashfees | -97 | 97 | 98 | 208 |
| Interest capitalized for construction in progress | NaN | 0 | 0 | 0 |
| Non-cash interest expense and amortization of debt discount | 1,070 | 887 | 1,002 | 1,556 |
| Accounts receivable | -302 | 6,473 | 1,310 | 3,686 |
| Inventory | 624 | -1,107 | -7,405 | 15,572 |
| Prepaid expenses and other current assets | 186 | -1,539 | -1,078 | 770 |
| Other assets | -5 | 8 | -12 | -450 |
| Accounts payable | -2,580 | 2,642 | -16,323 | 11,385 |
| Accrued liabilities | 3,341 | -692 | 1,893 | 646 |
| Operating lease liabilities | -247 | -292 | -128 | -467 |
| Other liabilities | 1,063 | 5,945 | -374 | -1,178 |
| Net cash used in operating activities | -4,310 | -162 | -11,250 | -39,478 |
| Purchases of property and equipment | 1,853 | 1,824 | 1,848 | 2,377 |
| Capital expenditures on construction in progress | NaN | 0 | 0 | 0 |
| Cash used in business acquisitions, net of cash acquired | 0 | 0 | 0 | 307 |
| Cost incurred for intangible assets | 107 | -163 | 112 | 723 |
| Net cash used in investing activities | -1,960 | -1,661 | -1,960 | -3,407 |
| Issuance of common stock, net of underwriters discount and issuance costs | NaN | 0 | 0 | 0 |
| Borrowings under oaktree credit agreement, net of debt discount and issuance costs | NaN | 0 | 24,500 | NaN |
| Borrowings on short term notes payable | NaN | 0 | 5,000 | 5,000 |
| Repayments on short term notes payable for insurance premium financing | 1,170 | 1,018 | NaN | NaN |
| Proceeds from stock option exercises | 1,008 | 7,206 | 31 | 352 |
| Taxpaymentsrelatedtoshareswithhelduponvesting ofrestrictedstock | 702 | 134 | 77 | 426 |
| Net cash used in financing activities | -864 | 6,054 | 29,454 | 4,926 |
| Effect of exchange rate changes on cash and cash equivalents | -337 | 717 | -259 | 2,251 |
| Net decrease in cash and cash equivalents | -7,471 | 4,948 | 15,985 | -35,708 |
| Cash and cash equivalents at beginning of period | 75,572 | 70,624 | 90,347 | NaN |
| Cash at end of period | 68,101 | 75,572 | 70,624 | NaN |
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)